Nuclein Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 77

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $15.7M

  • Investors
  • 9

Nuclein General Information

Description

Developer of a rapid PCR testing system designed to deliver lab results at the point of care. The company's system offers a DASH Rapid PCR (Polymerase Chain Reaction) system-of-care instrument with test cartridges that can run a wide variety of sample types, enabling healthcare providers to make treatment decisions with minimal hands-on time.

Contact Information

Website
www.nuclein.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 8305 Cross Park Drive
  • Austin, TX 78754
  • United States
+1 (888)
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Vertical(s)
Corporate Office
  • 8305 Cross Park Drive
  • Austin, TX 78754
  • United States
+1 (888)

Nuclein Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nuclein Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Later Stage VC 27-Oct-2026 $15.7M Completed Generating Revenue
9. Later Stage VC 04-Feb-2026 Completed Generating Revenue
8. Accelerator/Incubator 22-Mar-2023 Completed Generating Revenue
7. Debt - General 16-Nov-2023 Cancelled Generating Revenue
6. Later Stage VC (Series B2) 31-Aug-2022 Completed Generating Revenue
5. Early Stage VC (Series B) 25-Mar-2021 Completed Generating Revenue
4. Early Stage VC 18-Feb-2020 Cancelled Generating Revenue
3. Early Stage VC (Series A) 01-Jan-2020 Completed Generating Revenue
2. Angel (individual) 10-Sep-2019 $420K $420K Completed Generating Revenue
1. University Spin-Out 01-Jan-2017 Completed Startup
To view Nuclein’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Nuclein Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a rapid PCR testing system designed to deliver lab results at the point of care. The company's system offer
Diagnostic Equipment
Austin, TX
77 As of 2026

Philadelphia, PA
 

San Jose, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Nuclein Competitors (3)

One of Nuclein’s 3 competitors is Biomeme, a Venture Capital-Backed company based in Philadelphia, PA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Biomeme Venture Capital-Backed Philadelphia, PA
Visby Medical Venture Capital-Backed San Jose, CA
ACON Laboratories Corporate Backed or Acquired San Diego, CA
You’re viewing 3 of 3 competitors. Get the full list »

Nuclein Patents

Nuclein Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2024073366-A2 Methods of stabilizing a reducing agent Inactive 26-Sep-2022
WO-2024073366-A3 Methods of stabilizing a reducing agent Inactive 26-Sep-2022
US-20240226887-A1 Analyte detection cartridge and methods of use thereof Pending 27-Apr-2021
US-20240002916-A1 Direct lysis apparatus and methods for molecular diagnostics Pending 23-Nov-2020
EP-4247934-A1 Apparatus and methods for molecular diagnostics Inactive 17-Nov-2020 B01L7/52
To view Nuclein’s complete patent history, request access »

Nuclein Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nuclein Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
ACC Bioscience Incubator Accelerator/Incubator
Trinity Investors Asset Manager Minority
Angel (individual) Minority
Angel (individual) Minority
Angel (individual) Minority
You’re viewing 5 of 9 investors. Get the full list »

Nuclein Acquisitions (1)

Nuclein’s most recent deal was a Merger/Acquisition with Minute Molecular. The deal was made on 12-May-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Minute Molecular 12-May-2023 Merger/Acquisition Diagnostic Equipment
To view Nuclein’s complete acquisitions history, request access »

Nuclein FAQs

  • When was Nuclein founded?

    Nuclein was founded in 2017.

  • Where is Nuclein headquartered?

    Nuclein is headquartered in Austin, TX.

  • What is the size of Nuclein?

    Nuclein has 77 total employees.

  • What industry is Nuclein in?

    Nuclein’s primary industry is Diagnostic Equipment.

  • Is Nuclein a private or public company?

    Nuclein is a Private company.

  • What is Nuclein’s current revenue?

    The current revenue for Nuclein is .

  • How much funding has Nuclein raised over time?

    Nuclein has raised $68.9M.

  • Who are Nuclein’s investors?

    ACC Bioscience Incubator, Trinity Investors, , , and are 5 of 9 investors who have invested in Nuclein.

  • Who are Nuclein’s competitors?

    Biomeme, Visby Medical, and ACON Laboratories are competitors of Nuclein.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process